GE Yokogawa sees exports hit by rising yen:
This article was originally published in Clinica
Executive Summary
GE Yokogawa Medical Systems saw sales rise 6.2% in fiscal 1995 (ended November) to ¥2,000 million ($766 million). Income decreased 5.6% to Yen8,440 million, reports Japan Medical Review. Domestic sales totalled Yen59,400 million, up 9.5% over the previous year, while exports were affected by the appreciating yen, falling 1.5% to Yen22,600 million. GEYMS expects to report sales of Yen99,300 million in fiscal 1996.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.